Near point-of-care adoption of Cepheid Xpert® Flu/RSV XC testing within an integrated healthcare delivery network

Diagn Microbiol Infect Dis. 2019 May;94(1):28-29. doi: 10.1016/j.diagmicrobio.2018.11.013. Epub 2018 Nov 23.

Abstract

Flu/RSV testing was implemented in out-patient clinic-based physician office laboratories throughout Pennsylvania. On-site testing reduced the collect-to-result time by 70% when compared to testing in a centralized core laboratory; over- or under-treatment for influenza A and B (measured by anti-viral prescription) was reduced by 15% (P < 0.0001). Antimicrobial prescription was not affected by on-site testing.

Keywords: Flu; Flu test; Point-of-care; RSV.

Publication types

  • Evaluation Study

MeSH terms

  • Ambulatory Care / methods*
  • Humans
  • Influenza, Human / diagnosis*
  • Molecular Diagnostic Techniques / methods*
  • Pennsylvania
  • Point-of-Care Systems*
  • Respiratory Syncytial Virus Infections / diagnosis*
  • Time